Anna Castañé

2.0k total citations
40 papers, 1.6k citations indexed

About

Anna Castañé is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Anna Castañé has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cellular and Molecular Neuroscience, 19 papers in Pharmacology and 13 papers in Molecular Biology. Recurrent topics in Anna Castañé's work include Neuroscience and Neuropharmacology Research (26 papers), Neurotransmitter Receptor Influence on Behavior (22 papers) and Cannabis and Cannabinoid Research (11 papers). Anna Castañé is often cited by papers focused on Neuroscience and Neuropharmacology Research (26 papers), Neurotransmitter Receptor Influence on Behavior (22 papers) and Cannabis and Cannabinoid Research (11 papers). Anna Castañé collaborates with scholars based in Spain, Belgium and Uruguay. Anna Castañé's co-authors include Rafaël Maldonado, Olga Valverde, Catherine Ledent, Francesc Artigas, Marc Parmentier, Trevor W. Robbins, David E. H. Theobald, Analı́a Bortolozzi, Noemí Santana and Fernando Berrendero and has published in prestigious journals such as Biological Psychiatry, Cerebral Cortex and British Journal of Pharmacology.

In The Last Decade

Anna Castañé

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Castañé Spain 22 1.2k 599 543 342 218 40 1.6k
Lynne E. Rueter United States 28 779 0.7× 224 0.4× 780 1.4× 317 0.9× 226 1.0× 51 1.8k
John Mastropaolo United States 24 1.1k 0.9× 158 0.3× 787 1.4× 317 0.9× 181 0.8× 66 1.8k
Plínio Casarotto Finland 19 541 0.5× 369 0.6× 204 0.4× 170 0.5× 236 1.1× 46 1.1k
Frédérique Chaperon Switzerland 16 1.3k 1.1× 975 1.6× 470 0.9× 317 0.9× 99 0.5× 22 1.9k
Miquel Martín Spain 19 1.4k 1.2× 971 1.6× 457 0.8× 384 1.1× 93 0.4× 24 1.9k
Rudy Schreiber Netherlands 30 1.6k 1.4× 508 0.8× 1.3k 2.4× 359 1.0× 148 0.7× 72 2.6k
Nazzareno Cannella Italy 22 811 0.7× 192 0.3× 411 0.8× 467 1.4× 95 0.4× 60 1.4k
Sheketha R. Hauser United States 22 858 0.7× 166 0.3× 512 0.9× 255 0.7× 121 0.6× 61 1.3k
Tori L. Schaefer United States 30 974 0.8× 206 0.3× 589 1.1× 604 1.8× 133 0.6× 63 2.2k

Countries citing papers authored by Anna Castañé

Since Specialization
Citations

This map shows the geographic impact of Anna Castañé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Castañé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Castañé more than expected).

Fields of papers citing papers by Anna Castañé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Castañé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Castañé. The network helps show where Anna Castañé may publish in the future.

Co-authorship network of co-authors of Anna Castañé

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Castañé. A scholar is included among the top collaborators of Anna Castañé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Castañé. Anna Castañé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castañé, Anna, Albert Adell, Leticia Campa, et al.. (2024). A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease. Neurotherapeutics. 21(5). e00439–e00439. 2 indexed citations
2.
Campa, Leticia, et al.. (2020). Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine. Translational Psychiatry. 10(1). 427–427. 19 indexed citations
3.
Gasull-Camós, Júlia, et al.. (2019). Astrocyte control of glutamatergic activity: Downstream effects on serotonergic function and emotional behavior. Neuropharmacology. 166. 107914–107914. 45 indexed citations
4.
Gasull-Camós, Júlia, et al.. (2018). Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex. Neuropharmacology. 139. 41–51. 19 indexed citations
5.
Scorza, Cecilia, et al.. (2018). Involvement of the GluN2C subunit in the behavioral syndrome induced by non-competitive NMDA antagonists. European Neuropsychopharmacology. 28. S37–S37. 1 indexed citations
6.
Gasull-Camós, Júlia, et al.. (2017). Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats. Translational Psychiatry. 7(2). e1038–e1038. 54 indexed citations
7.
Castañé, Anna, Lucila Kargieman, Pau Celada, Analı́a Bortolozzi, & Francesc Artigas. (2015). 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine. European Neuropsychopharmacology. 25(8). 1353–1361. 14 indexed citations
8.
Castañé, Anna, Noemí Santana, & Francesc Artigas. (2015). PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Psychopharmacology. 232(21-22). 4085–4097. 59 indexed citations
9.
Bortolozzi, Analı́a, Anna Castañé, Noemí Santana, et al.. (2012). New antidepressant strategy based on acute siRNA silencing of 5-HT1A autoreceptors. Molecular Psychiatry. 17(6). 567–567. 13 indexed citations
10.
Ferrés‐Coy, Albert, Noemí Santana, Anna Castañé, et al.. (2012). Acute 5-HT1A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions. Psychopharmacology. 225(1). 61–74. 56 indexed citations
11.
Masana, Mercè, Anna Castañé, Noemí Santana, Analı́a Bortolozzi, & Francesc Artigas. (2012). Noradrenergic antidepressants increase cortical dopamine: Potential use in augmentation strategies. Neuropharmacology. 63(4). 675–684. 23 indexed citations
12.
Castañé, Anna, et al.. (2010). Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801. Neuropharmacology. 59(1-2). 112–120. 26 indexed citations
13.
Castañé, Anna, David E. H. Theobald, & Trevor W. Robbins. (2010). Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats. Behavioural Brain Research. 210(1). 74–83. 148 indexed citations
14.
Barbano, M. Flavia, Anna Castañé, Elena Martín‐García, & Rafaël Maldonado. (2009). Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test. Psychopharmacology. 205(3). 475–487. 16 indexed citations
15.
Castañé, Anna, Guadalupe Sòria, S.M.O. Hourani, et al.. (2008). Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A2Areceptor knockout mice. British Journal of Pharmacology. 155(5). 757–766. 20 indexed citations
16.
Castañé, Anna, Francesc Artigas, & Analı́a Bortolozzi. (2008). The absence of 5-HT1A receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex. Psychopharmacology. 200(2). 281–290. 17 indexed citations
17.
Boulougouris, Vasileios, Anna Castañé, & Trevor W. Robbins. (2008). Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior. Psychopharmacology. 202(4). 611–620. 91 indexed citations
18.
Castañé, Anna, Evelyne Célèrier, Miquel Martín, et al.. (2005). Development and expression of neuropathic pain in CB1 knockout mice. Neuropharmacology. 50(1). 111–122. 34 indexed citations
19.
Castañé, Anna, Rafaël Maldonado, & Olga Valverde. (2004). Role of different brain structures in the behavioural expression of WIN 55,212‐2 withdrawal in mice. British Journal of Pharmacology. 142(8). 1309–1317. 24 indexed citations
20.
Berrendero, Fernando, Anna Castañé, Catherine Ledent, et al.. (2003). Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1/A2a double knockout mice. European Journal of Neuroscience. 17(2). 315–324. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynne E. Rueter Breakdown of academic impact, for papers by John Mastropaolo Breakdown of academic impact, for papers by Plínio Casarotto Breakdown of academic impact, for papers by Frédérique Chaperon Breakdown of academic impact, for papers by Miquel Martín Breakdown of academic impact, for papers by Rudy Schreiber Breakdown of academic impact, for papers by Nazzareno Cannella Breakdown of academic impact, for papers by Sheketha R. Hauser Breakdown of academic impact, for papers by Tori L. Schaefer
Rankless by CCL
2026